MET MetLife, Inc.

EQH is expanding fee-based businesses, with Wealth Management and Asset Management boosting recurring revenues and diversifying earnings.

Michael Burry just swapped unlimited-horizon short positions for expiring put contracts on Micron, accepting a hard deadline to be right before a stock up 550% in a year reports earnings in hours.

Michael Burry Loads Up on Long-Dated AI Puts After Fresh Bubble Warning

Burry has replaced his common-stock shorts with put options across several AI-linked names, saying new research has convinced him to move his timelines forward.

Voya Financial's Employee Benefits segment is improving profitability as better underwriting, pricing actions and expense discipline lift margins.

Bond-heavy US life and P&C insurers are suddenly back in the spotlight as 10-year and 30-year Treasury yields hover around two-decade highs near 5%. When the risk-free rate jumps, long-term portfolios and equity valuations both feel it, for better or worse. This article walks through three large insurers from our screener that appear closely tied to this rate shock and explains how their exposure might matter for your portfolio decisions. The insurers highlighted below are only a small...

The new funding plan is intended to support further AI product development, alongside deployment support for use by financial institutions.

In an excerpt from his new book, ‘What Could Possibly Go Right?’, Danny Meyer reflects on his decision to close Tabla—and explains his efforts to do so humanely.

MET's Group Benefits earnings jump 25% in Q2 2026, fueled by stronger underwriting and demand, but some mortality gains may fade.

Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Life insurers generally benefit from higher rates, but there are some negatives to consider.

Record annuity demand has put MetLife (MET) firmly in focus after the insurer reported strong second quarter results tied to retirement solutions, pension risk transfers, and investment income from a supportive yield backdrop. MetLife’s share price has climbed in recent months, with a 30 day share price return of 2.03% and a 90 day gain of 13.39%. The year to date share price return of 20.82% sits alongside a 1 year total shareholder return of 26.08% and a 5 year total shareholder return of...

Record annuity demand creates opportunities for Prudential, Principal Financial and MetLife as retirement needs and pension solutions grow.

LNC is shifting from capital rebuilding to flexibility, with stronger liquidity, lower leverage and new room to pursue growth and returns.

Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.

MetLife has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.8%. The stock now trades at $95.81, marking a 35.4% gain. This run-up might have investors contemplating their next move.

Disposition was non-discretionary, executed to cover tax obligations from restricted stock unit vesting. McCallion retains 269,137 direct shares worth $25.4 million.

MetLife has outperformed the broader market over the past year, while analysts remain somewhat bullish on its future prospects.

MET's diversified portfolio, strong cash generation and global growth support premium gains, while investment income volatility remains a key risk.

Chariot Re said the new capital will help it scale its life and annuity reinsurance business and pursue a growing pipeline of diversified opportunities.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

SanDisk, Phillips 66, and MetLife added $27 billion in combined buyback capacity, with SanDisk's $14 billion authorization following a 500% share price surge in 2026.

Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Seagate Technology Holdings PLC (STX) and AT&T Inc. (T), as well as a micro-cap stock, Daily Journal Corporation (DJCO).

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how MetLife (NYSE:MET) and the rest of the life insurance stocks fared in Q2.

MetLife has delivered a strong 82.3% total return over the past five years, yet today the stock screens as expensive on traditional multiples while an Excess Returns intrinsic value estimate points to meaningful upside, so investors are getting mixed signals on what the current US$96.73 share price really implies. Over five years, MetLife has returned 82.3%, which puts recent valuation concerns in the context of a stock that has already created substantial shareholder value over a longer...

When the 30-year Treasury topped 5%, two dividend stocks moved in completely opposite directions on the same day, and the reason has nothing to do with their yields.

BlackRock, DLocal, Chevron, Williams Companies, and MetLife pay solid dividends and carry favorable analyst ratings, offering income investors growth exposure and price target upside.

MetLife’s second quarter results were marked by broad-based earnings growth, with market participants rewarding the company’s performance as shares rose notably after the announcement. Management attributed the positive momentum to strong underwriting across all segments, increased international sales, and disciplined expense controls. CEO Michel Khalaf pointed to the impact of MetLife’s “New Frontier strategy,” which leverages recurring revenue streams and a diverse global portfolio, emphasizin

Adjusted earnings surged 15% on strong underwriting and broad-based volume growth.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

MetLife (NYSE:MET) reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted earnings per share increased 20%, while adjusted return on equity reached 17%, the top end of the company’s 15% to 17% annual target range. Presi

American International beats Q2 earnings estimates as stronger underwriting and lower catastrophe losses offset weaker investment income.

Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.

MetLife has outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.

MetLife (NYSE: MET) announced that its board of directors has approved a new US$3b share repurchase authorization. The buyback authorization adds a fresh layer to MetLife's capital return plans and offers the board flexibility over future share repurchases. The decision signals the insurer's confidence in its balance sheet and long term capital allocation approach. MetLife is far from the only large insurer using buybacks and dividends to return capital to investors. It is therefore worth...

MET tops Q2 EPS estimates as higher investment income, favorable underwriting and business volume growth lift earnings despite higher expenses.

Moby summary of MetLife, Inc.'s Q2 2026 earnings call

By Elizabeth Howcroft PARIS, Aug 6 (Reuters) - Investor sentiment rebounded on Thursday, as optimism about company earnings drove stock markets to new highs and traders interpreted a proposed deal

The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Global insurance giant MetLife (NYSE:MET) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.9% year on year to $19.15 billion. Its non-GAAP profit of $2.43 per share was 6.2% above analysts’ consensus estimates.

Corebridge (CRBG) delivered earnings and revenue surprises of +3.70% and -4.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Commercial pricing, investment income and underwriting trends are in focus as Allstate, MetLife and Radian Group prepare to report Q2 earnings.

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.

AFL's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure ahead of its Aug. 6 Q2 earnings report.

MET heads into Q2 results with rising earnings estimates and expected strength in Group Benefits and Retirement & Income Solutions. Will it deliver a beat?

Evaluate the expected performance of MetLife (MET) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Fidelity National Financial (FNF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MetLife stock has nearly doubled investors' money over the past five years, yet there is a clear split in what the current price implies, with the Excess Returns intrinsic value estimate pointing to a sizeable discount while earnings-based multiples lean in the opposite direction. Over the past five years, MetLife has delivered a 91.4% total return, which puts more pressure on today's valuation to be supported by future cash flows rather than past price gains. The valuation can be helped if...